当前位置: X-MOL 学术Arch. Biochem. Biophys. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
IL-35 promotes microglial M2 polarization in a rat model of diabetic neuropathic pain.
Archives of Biochemistry and Biophysics ( IF 3.8 ) Pub Date : 2020-03-07 , DOI: 10.1016/j.abb.2020.108330
Yinghai Jiang 1 , Jing Wang 1 , Haiqin Li 1 , Lingjie Xia 1
Affiliation  

Switching microglial polarization from the pro-inflammatory M1 phenotype to the anti-inflammatory M2 phenotype represents a novel therapeutic strategy for diabetic neuropathic pain (DNP). This study aims to determine the role and mechanism of interleukin (IL)-35 in regulating microglial M1/M2 polarization in DNP. A rat model of DNP was induced by a single streptozocin injection and recombinant IL-35 (rIL-35) was then intrathecally administered to the rats for 14 days. The mechanical withdrawal threshold (MWT) and thermal withdrawal latency (TWL) were measured to assess the therapeutic effect of IL-35. Highly aggressive proliferating immortalized (HAPI), a rat microglia cell line, was treated with lipopolysaccharide (LPS) for M1 polarization or IL-4 for M2 polarization. The M1 markers (CD68, iNOS, TNF-α, IL-6) and M2 markers (CD206, Arg-1, IL-10) were examined. rIL-35 administration in DNP model rats elevated MWT and TWL, induced microglial polarization toward the M2 phenotype, suppressed JNK signaling and activated JAK2/STAT6 signaling. In vitro assay confirmed that rIL-35 induced microglial M2 polarization in HAPI cells through inhibiting JNK signaling and activating JAK2/STAT6 signaling. Collectively, the mechanism underlying therapeutic effect of IL-35 on DNP may relate to its promotion of microglial M2 polarization by regulating JNK signaling and JAK2/STAT6 signaling.

中文翻译:

IL-35在糖尿病性神经性疼痛的大鼠模型中促进小胶质细胞M2极化。

将小胶质细胞极化从促炎性M1表型转换为消炎性M2表型代表了糖尿病性神经性疼痛(DNP)的新型治疗策略。本研究旨在确定白介素(IL)-35在调节DNP中小胶质细胞M1 / M2极化中的作用和机制。通过单次链脲佐菌素注射诱导DNP的大鼠模型,然后将鞘内施用IL-35(rIL-35)重组给大鼠。测量机械撤药阈值(MWT)和热撤药潜伏期(TWL)以评估IL-35的治疗效果。用脂多糖(LPS)处理M1极化或使用IL-4处理M2极化,将高侵袭性永生化(HAPI)大鼠小胶质细胞系进行处理。M1标记(CD68,iNOS,TNF-α,IL-6)和M2标记(CD206,Arg-1,检查IL-10)。在DNP模型大鼠中进行rIL-35给药可升高MWT和TWL,诱导小胶质细胞向M2表型极化,抑制JNK信号传导并激活JAK2 / STAT6信号传导。体外测定证实,rIL-35通过抑制JNK信号传导和激活JAK2 / STAT6信号传导诱导HAPI细胞中的小胶质细胞M2极化。总的来说,IL-35对DNP的治疗作用的潜在机制可能与其通过调节JNK信号传导和JAK2 / STAT6信号传导促进小胶质细胞M2极化有关。体外测定证实,rIL-35通过抑制JNK信号传导和激活JAK2 / STAT6信号传导诱导HAPI细胞中的小胶质细胞M2极化。总的来说,IL-35对DNP的治疗作用的潜在机制可能与其通过调节JNK信号传导和JAK2 / STAT6信号传导促进小胶质细胞M2极化有关。体外测定证实,rIL-35通过抑制JNK信号传导和激活JAK2 / STAT6信号传导诱导HAPI细胞中的小胶质细胞M2极化。总的来说,IL-35对DNP的治疗作用的潜在机制可能与其通过调节JNK信号传导和JAK2 / STAT6信号传导促进小胶质细胞M2极化有关。
更新日期:2020-03-09
down
wechat
bug